Glasgow Micah D K, Chougule Mahavir B
J Biomed Nanotechnol. 2015 Nov;11(11):1859-98. doi: 10.1166/jbn.2015.2145.
Nanotechnology and combination therapy are two major fields that show great promise in the treatment of cancer. The delivery of drugs via nanoparticles helps to improve drug's therapeutic effectiveness while reducing adverse side effects associated wifh high dosage by improving their pharmacokinetics. Taking advantage of molecular markers over-expressing on tumor tissues compared to normal cells, an "active" molecular marker targeted approach would be-beneficial for cancer therapy. These actively targeted nanoparticles would increase drug concentration at the tumor site, improving efficacy while further reducing chemo-resistance. The multidisciplinary approach may help to improve the overall efficacy in cancer therapy. This review article summarizes recent developments of targeted multifunctional nanoparticles in the delivery, of various drugs for a combinational chemotherapy approach to cancer treatment and imaging.
纳米技术和联合疗法是癌症治疗领域中展现出巨大前景的两个主要领域。通过纳米颗粒递送药物有助于提高药物的治疗效果,同时通过改善其药代动力学来减少与高剂量相关的不良副作用。与正常细胞相比,利用肿瘤组织上过度表达的分子标记物,“主动”分子标记物靶向方法将有利于癌症治疗。这些主动靶向纳米颗粒会增加肿瘤部位的药物浓度,提高疗效,同时进一步降低化疗耐药性。多学科方法可能有助于提高癌症治疗的整体疗效。这篇综述文章总结了靶向多功能纳米颗粒在递送各种药物用于联合化疗癌症治疗和成像方面的最新进展。
Chin J Cancer. 2010-9
Eur J Pharm Biopharm. 2015-6
Curr Drug Discov Technol. 2009-3
Adv Drug Deliv Rev. 2013-7-21
Adv Colloid Interface Sci. 2017-2-15
Int J Med Sci. 2025-6-12
Open Res Eur. 2024-10-25
Pharmaceutics. 2023-8-29
MedComm (2020). 2023-1-11
Cancer Nanotechnol. 2012
J Biomed Nanotechnol. 2014-11
J Biomed Nanotechnol. 2014-9
J Biomed Nanotechnol. 2014-9
J Biomed Nanotechnol. 2014-9
J Biomed Nanotechnol. 2014-10
J Biomed Nanotechnol. 2014-10
J Biomed Nanotechnol. 2014-10
J Biomed Nanotechnol. 2014-10
J Biomed Nanotechnol. 2014-10